Death receptor 4 and bladder cancer risk

Cancer Research

Volumn 63, Issue 6, 2003, Pages 1157-1159

  Hazra, Aditi ^a   Chamberlain, Robert M ^a   Grossman, H Barton ^a   Zhu, Yong ^a   Spitz, Margaret R ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR 4; RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; EXON; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SMOKING;

ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, TUMOR NECROSIS FACTOR; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 0037444387     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wiley, S., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nichol, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., and Smith, C. A. Identification and characterization of new member of the TNF family that induces apoptosis. Immunity, 3: 673-682, 1995.
2. Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., and Askenazi, A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem., 271: 12687-12690.
3. Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., and Dixit, V. M. The receptor for the cytotoxic ligand TRAIL. Science (Wash. DC), 276: 111-113, 1997.
4. Ashkenazi, A., and Dixit, V. M. Death receptors: signaling and modulation. Science (Wash. DC), 281: 1305-1308, 1998.
5. Ashkenazi, A., and Dixit, V. M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol., 11: 255-260, 1999.
6. Askenazi, A. Targeting death and decoy receptors of the tumor-necrosis factor superfamily. Nat. Rev. Cancer, 2: 420-430, 2002.
7. Baeuta, T. M., and Hiscott, J. On the TRAIL to apoptosis. Cytokine Growth Factor Rev., 13: 199-207, 2002.
8. Hymowitz, S. G., Christinger, H. W., Fuh, G., Ultsch, M., O'Connell, M., Kelley, R. F., Ashkenazi, A., and de Vos, A. M. Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol. Cell, 4: 563-571, 1999.
9. Fisher, M. J., Virmani, A. K., Wu, L., Aplenc, R., Harper, J. C., Powell, S. M., Rebbeck, T. R., Sidransky, D., Gazdar, A. F., and El-Deiry, W. S. Nucleotide substitution in the ectodomain of TRAIL receptor DR4 is associated with lung cancer and head and neck cancer. Clin. Cancer Res., 7: 1688-1697, 2001.
10. Griffith, T. S., and Lynch, D. H. TRAIL a molecule with multiple receptors and control mechanism. Curr. Opin. Immunol., 10: 559-563, 1998.
11. Singh, A., Ni, J., and Aggarwal, B. B. Death domain receptors and their role in cellular demise. J. Interferon Cytokine Res., 18: 439-450, 1998.
12. Kim, K., Fisher, M. J., Xu, S., and El-Diery, W. S. Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin. Cancer Res., 6: 335-346, 2000.
13. Guan, B., Yue, P., Clayman, G. L., and Sun, S. Y. Evidence that the Death Receptor DR4 is a DNA damage-inducible, p53-regulated gene. J. Cell. Physiol., 188: 98-105, 2001.
14. Zhao, H., Grossman, H. B., Spitz, M. R., Lerner, S. P., Zhang, K., and Wu, X. Plasma levels of insulin-like growth factor and binding protein-3 and their association with bladder cancer risk. J. Urol., in press, 2002.
15. Nagane, M., Huang, H. J., and Cavenee, W. K. The potential of TRAIL for cancer chemotherapy. Apoptosis, 6: 191-197, 2001.
16. Wu, X., Zhao, H., Amos, C. I., Shete, S., Makan, N., Hong, W. K., Kadlubar, F. F., and Spitz, M. R. p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J. Natl. Cancer Inst. (Bethesda), 94: 681-690, 2002.
17. Zang, E. A., and Wynder, E. L. Differences in lung cancer risk between men and women: examination of the evidence. J. Natl. Cancer Inst. (Bethesda), 88: 183-192, 1996.
18. Ryberg, D., Hewer, A., Phillips, D. H., and Haugen, A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res., 54: 5801-5803, 1994.